Journal of Diabetes Investigation
Frailty and low body mass linked to stopping one diabetes drug class
Over 180 days, an estimated 9.1% of 616 Japanese adults aged 75 or older stopped sodium-glucose cotransporter 2 inhibitors because of drug-specific adverse events.Over 180 days, an estimated 9.1% of 616 Japanese adults aged 75 or older stopped sodium-glucose cotransporter 2 inhibitors because of drug-specific adverse events.
Cohort · 616 peopleInterventions
Who was studied616 Japanese adults aged ≥75 years, 180 days
What changedDrug discontinuation was 27.1% for scores of at least 5 on a frailty scale, versus 7.2% for lower scores
The catchInvestigators assigned frailty scores from medical records